JUPITER BIOLIFE
LIVE

Serial Number

90813435

Owner

JUPITER BIOLIFE, LLC

Attorney

Blake P. Hurt

First Use Date

Jan 1, 2023

Filing Date

Jul 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

JUPITER BIOLIFE Trademark

Serial Number: 90813435 • Registration: 7190285

JUPITER BIOLIFE is a trademark filed by JUPITER BIOLIFE, LLC on July 6, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

JUPITER BIOLIFE, LLC (6 trademarks)

858 Dahoon Circle
Venice, FL 34293

Entity Type: 16

Trademark Details

Filing Date

July 6, 2021

Registration Date

October 10, 2023

First Use Anywhere

January 1, 2023

First Use in Commerce

January 1, 2023

Published for Opposition

May 3, 2022

Goods & Services

Biological preparations for the treatment of immune-related disorders, Parkinson's disease, arthritis, periodontal disease, heart defects, acne, allergies, anxiety, obesity, asthma, cancer, bronchitis, chronic fatigue syndrome, chronic obstructive pulmonary disorder, coeliac disease, cough, Crohn's disease, Cystic fibrosis, deep vein thrombosis, dementia, diabetes, depression, epilepsy, erectile dysfunction, seizures, fibromyalgia, gout, headaches, heart failure, high blood pressure, Huntington's disease, hyperglycemia, insomnia, irritable bowel syndrome, liver disease, lyme disease, Lupus, Meningitis, Migraines, Multiple myeloma, multiple sclerosis, osteoporosis, psoriasis, rosacea, schizophrenia, shingles, stroke, sunburn, tinnitus, trigeminal neuralgia, and vertigo; Natural biomaterials for augmentation of bone and tissue for medical purposes; Therapeutic pharmaceutical for the treatment of immune-related disorders, Parkinson's disease, arthritis, periodontal disease, heart defects, acne, allergies, anxiety, obesity, asthma, cancer, bronchitis, chronic fatigue syndrome, chronic obstructive pulmonary disorder, coeliac disease, cough, Crohn's disease, Cystic fibrosis, deep vein thrombosis, dementia, diabetes, depression, epilepsy, erectile dysfunction, seizures, fibromyalgia, gout, headaches, heart failure, high blood pressure, Huntington's disease, hyperglycemia, insomnia, irritable bowel syndrome, liver disease, lyme disease, Lupus, Meningitis, Migraines, Multiple myeloma, multiple sclerosis, osteoporosis, psoriasis, rosacea, schizophrenia, shingles, stroke, sunburn, tinnitus, trigeminal neuralgia, and vertigo

On-line wholesale and retail store services featuring dental, medical, facial, and cosmeceutical products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 10, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 6, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 5, 2023 CNPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 24, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 24, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 24, 2023 COAR
STATEMENT OF USE PROCESSING COMPLETE
Jul 18, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 17, 2023 AITU
USE AMENDMENT FILED
Jun 20, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 20, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 21, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 21, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 21, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 30, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 30, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 30, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 30, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 24, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2021 NWOS
NEW APPLICATION ENTERED
Jul 9, 2021 NWAP